The expectations that UCP1 could play a protective role in CV health were based on the collected experimental evidence and epidemiological reports, which demonstrated an inverse association between UCP1 transcription and insulin resistance, dyslipidemia and obesity [40]. The gene discussed is UCP1; the disease is obesity disorder.